Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatment.
about
Levodopa-induced plasticity: a double-edged sword in Parkinson's disease?Age-related alterations in the expression of genes and synaptic plasticity associated with nitric oxide signaling in the mouse dorsal striatumChronic methylphenidate exposure during adolescence reduces striatal synaptic responses to ethanol.Chronic levodopa administration followed by a washout period increased number and induced phenotypic changes in striatal dopaminergic cells in MPTP-monkeysA neoHebbian framework for episodic memory; role of dopamine-dependent late LTP.Anatomy of Graft-induced Dyskinesias: Circuit Remodeling in the Parkinsonian StriatumM4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced DyskinesiaAberrant restoration of spines and their synapses in L-DOPA-induced dyskinesia: involvement of corticostriatal but not thalamostriatal synapsesMaladaptive Synaptic Plasticity in L-DOPA-Induced DyskinesiaOpioid system in L-DOPA-induced dyskinesia.Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation.Striatal Signaling in L-DOPA-Induced Dyskinesia: Common Mechanisms with Drug Abuse and Long Term Memory Involving D1 Dopamine Receptor Stimulation.Tardive dyskinesia is caused by maladaptive synaptic plasticity: a hypothesis.The role of neuroplasticity in dopaminergic therapy for Parkinson disease.Differential effects of the NMDA receptor antagonist MK-801 on dopamine receptor D1- and D2-induced abnormal involuntary movements in a preclinical model.GluN2A and GluN2B NMDA receptor subunits differentially modulate striatal output pathways and contribute to levodopa-induced abnormal involuntary movements in dyskinetic ratsClinical features, pathophysiology, and treatment of levodopa-induced dyskinesias in Parkinson's disease.Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia.L-dopa treatment duration versus Parkinson's disease progression: the dorsal-ventral divide.Ammonia-induced deficit in corticostriatal long-term depression and its amelioration by zaprinast.Abnormal cortical and brain stem plasticity in Gilles de la Tourette syndrome.Dysregulation of BET proteins in levodopa-induced dyskinesia.
P2860
Q27002626-318E8053-7B11-44BF-A62F-39C42F173F88Q28390090-F5271C3F-2888-40D3-B12B-DD72641B603DQ34180506-8501E519-2BBF-46BD-96BA-6B7BEA0F198AQ34506001-26A00B34-ADF9-4ADC-9F1D-69E6BC4F90B4Q35244029-DCAEFB85-518B-46D2-9F87-B9EB11D208AAQ36034592-A2D9AA95-18A3-4B6E-80B8-28B2D1A48700Q36892615-1CD2F013-E0FC-41D4-9CB1-73379EC18593Q37048087-74AD07C8-29D9-449B-8345-43648B423046Q37516434-3DE5899E-6D47-47FD-BF91-2CAE07BDA17EQ37589209-C4415CB4-0F45-40B0-8072-428A7B1B84E5Q37924629-0D3D982C-3B5D-44D9-BF8D-4717FB40BE71Q37925513-2ADFA7A6-9F75-4D34-BC60-C70D0E8E1A41Q38032249-5DD3A81E-C12B-42FE-80AE-965E6FED36CCQ38099197-5628C19D-D9D0-4C4D-91D8-1649DD25B25BQ39975159-90088550-DC11-4328-9A1A-80D28510D8DCQ40789803-33583DF8-4B3D-4B07-82D2-1BA7C28A2CE1Q41645312-AB47F2B1-7655-43A4-9A57-912230BB6B13Q42177230-A2898645-7767-46BE-A54A-B4D71A4D2F2BQ42562906-D5B170E6-0F98-4BBD-B956-37C5F33F74A8Q48491950-C02F541D-6596-45B7-9CC5-F18FC7D092EEQ48886165-616A4B79-4F12-44DB-9171-D04D881D993EQ50592833-A81753AF-9B10-48A1-897F-BBA6CEDE9579
P2860
Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatment.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Aberrant striatal plasticity i ...... following levodopa treatment.
@en
Aberrant striatal plasticity i ...... following levodopa treatment.
@nl
type
label
Aberrant striatal plasticity i ...... following levodopa treatment.
@en
Aberrant striatal plasticity i ...... following levodopa treatment.
@nl
prefLabel
Aberrant striatal plasticity i ...... following levodopa treatment.
@en
Aberrant striatal plasticity i ...... following levodopa treatment.
@nl
P2860
P921
P356
P1433
P1476
Aberrant striatal plasticity i ...... following levodopa treatment.
@en
P2093
Daniel J Lodge
P2860
P304
P356
10.1002/MDS.23245
P407
P577
2010-08-01T00:00:00Z